Sage Therapeutics Inc (FRA:SG7)
€ 5.79 -0.394 (-6.37%) Market Cap: 328.82 Mil Enterprise Value: -195.46 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 45/100

SAGE Therapeutics Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 03:30PM GMT
Release Date Price: €34.02 (+1.76%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

For those of you who don't know me, my name is Akash Tewari. I am a biotech analyst here at Jefferies. Today, I have the pleasure of hosting the Sage management team. Joining us today are Kimi Iguchi, Jim Doherty and Chris Benecchi. And we are going to...

Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer

Albert Robichaud. He was not able to make it today.

Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

Okay, my mistake. But either way, it's great to have you guys. That is true. So why don't we start off with heading into Kimi to give some brief introductory remarks, and then we'll get into our set of questions.

Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer

Great. Terrific. Thanks, Akash, and thanks for having us to the conference. We're excited to be here. I'm excited to be in Manhattan, it's been a while. But for those of you who aren't familiar with Sage, Sage is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot